JPY 9230.0
(-0.43%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 11.1 Billion | 645 Million | -16.3 Billion | -17.06 Billion | 4.94 Billion | 5.42 Billion |
Net Income | 8.11 Billion | -6.36 Billion | 17.15 Billion | -23.17 Billion | -521 Million | 1.29 Billion |
Depreciation & Amortization | 3.63 Billion | 3.61 Billion | 4.2 Billion | 4.79 Billion | 4.97 Billion | 4.9 Billion |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 1.38 Billion | -249 Million | -3.35 Billion | 3.51 Billion | 158 Million | 434 Million |
Other non-cash items | -2.02 Billion | 3.64 Billion | -34.3 Billion | -2.2 Billion | 335 Million | -1.2 Billion |
Investing Cash Flow | -5.91 Billion | -6.12 Billion | 42.89 Billion | -2.41 Billion | -3.49 Billion | -4.32 Billion |
Investments in PPE | -5.24 Billion | -6.99 Billion | -1.42 Billion | -4.07 Billion | -3.84 Billion | -4.39 Billion |
Acquisitions | -776 Million | 5 Million | 39.73 Billion | 164 Million | - | 3 Million |
Investment purchases | - | - | -39.73 Billion | -164 Million | - | - |
Sales/Maturities of investments | - | - | 6.24 Billion | 903 Million | 581 Million | - |
Other Investing Activities | 100 Million | 871 Million | 38.06 Billion | 764 Million | -231 Million | 67 Million |
Financing Cash Flow | -15.66 Billion | -8.93 Billion | 8.31 Billion | 19.83 Billion | -1.46 Billion | -1.88 Billion |
Debt repayment | -9.76 Billion | -7.86 Billion | -8.46 Billion | -7.52 Billion | -8.67 Billion | -8.9 Billion |
Dividends payments | -796 Million | -156 Million | - | -360 Million | -479 Million | -479 Million |
Common Stock Repurchased | -5 Billion | - | -1 Million | -1 Million | -1 Million | -2 Million |
Common Stock Issuance | -1 Million | - | 15 Billion | 27.81 Billion | 7.75 Billion | 7.55 Billion |
Other Financing Activities | -108 Million | -912 Million | 3.64 Billion | -90 Million | -67 Million | -42 Million |
Accounts receivables | -1.11 Billion | -1.86 Billion | -248 Million | 3.19 Billion | 61 Million | -346 Million |
Accounts payables | 175 Million | 148 Million | 53 Million | -749 Million | -87 Million | -67 Million |
Inventory | -63 Million | -82 Million | 62 Million | 121 Million | 51 Million | 109 Million |
Other working capital | 2.38 Billion | 1.54 Billion | -3.22 Billion | 946 Million | 133 Million | 325 Million |
Cash at beginning of period | 24.11 Billion | 38.61 Billion | 3.69 Billion | 3.34 Billion | 3.38 Billion | 4.3 Billion |
Cash at end of period | 13.67 Billion | 24.11 Billion | 38.61 Billion | 3.69 Billion | 3.34 Billion | 3.38 Billion |
Capital Expenditure | -5.24 Billion | -6.99 Billion | -1.42 Billion | -4.07 Billion | -3.84 Billion | -4.39 Billion |
Effect of forex changes on cash | 43 Million | -97 Million | 15 Million | -1 Million | -22 Million | -139 Million |
Net cash flow / Change in cash | -10.43 Billion | -14.5 Billion | 34.92 Billion | 349 Million | -40 Million | -916 Million |
Free Cash Flow | 5.86 Billion | -6.35 Billion | -17.73 Billion | -21.14 Billion | 1.1 Billion | 1.03 Billion |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 2.33 Billion | 1.66 Billion | 8.11 Billion | 3.48 Billion | 1.55 Billion | 2.42 Billion |
Depreciation & Amortization | - | - | 3.63 Billion | 957 Million | 960 Million | 860 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | 1.38 Billion | - | - | - |
Other non-cash items | -2.33 Billion | -1.66 Billion | -2.02 Billion | -3.48 Billion | -1.55 Billion | -2.42 Billion |
Investing Cash Flow | - | - | -5.91 Billion | - | - | - |
Investments in PPE | - | - | -5.24 Billion | - | - | - |
Acquisitions | - | - | -776 Million | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | 100 Million | - | - | - |
Financing Cash Flow | - | - | -15.66 Billion | - | - | - |
Debt repayment | - | - | -9.76 Billion | - | - | - |
Dividends payments | - | - | -796 Million | - | - | - |
Common Stock Repurchased | - | - | -5 Billion | - | - | - |
Common Stock Issuance | - | - | -1 Million | - | - | - |
Other Financing Activities | - | - | -108 Million | - | - | - |
Accounts receivables | - | - | -1.11 Billion | - | - | - |
Accounts payables | - | - | 175 Million | - | - | - |
Inventory | - | - | -63 Million | - | - | - |
Other working capital | - | - | 2.38 Billion | - | - | - |
Cash at beginning of period | - | - | 24.11 Billion | 17.44 Billion | 18.05 Billion | 19.79 Billion |
Cash at end of period | - | - | 13.67 Billion | 13.67 Billion | 17.44 Billion | 18.05 Billion |
Capital Expenditure | - | - | -5.24 Billion | - | - | - |
Effect of forex changes on cash | - | - | 43 Million | - | - | - |
Net cash flow / Change in cash | - | - | -10.43 Billion | -3.77 Billion | -604 Million | -1.73 Billion |
Free Cash Flow | - | - | 5.86 Billion | 1.91 Billion | 1.92 Billion | 1.72 Billion |
KLI
TRANSFD
300394
LXCHEM
SHTDF
TRIS3